Found: 20
Select item for more details and to access through your institution.
Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Electrocardiographic Effects of a Dietary Supplement Containing Ephedra and Caffeine—Reply.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Electrocardiographic and Hemodynamic Effects of a Multicomponent Dietary Supplement Containing Ephedra and Caffeine: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 2, p. 216, doi. 10.1001/jama.291.2.216
- By:
- Publication type:
- Article
Electrocardiographic Effects of an Ephedra-Free, Multicomponent Weight-Loss Supplement in Healthy Volunteers.
- Published in:
- Pharmacotherapy, 2005, v. 25, n. 5, p. 654, doi. 10.1592/phco.25.5.654.63581
- By:
- Publication type:
- Article
Anemia Management in Heart Failure: A Thick Review of Thin Data.
- Published in:
- Pharmacotherapy, 2004, v. 24, n. 6, p. 757, doi. 10.1592/phco.24.8.757.36072
- By:
- Publication type:
- Article
Acute Decompensated Heart Failure: A Contemporary Approach to Pharmacotherapeutic Management.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 8, p. 997, doi. 10.1592/phco.23.8.997.32873
- By:
- Publication type:
- Article
Criterion for Board Certification Needs Revision.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 4, p. 552, doi. 10.1177/1060028013513147
- By:
- Publication type:
- Article
Ranolazine in the management of chronic stable angina.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 23, p. 2331, doi. 10.2146/ajhp060042
- By:
- Publication type:
- Article
Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement.
- Published in:
- 2005
- By:
- Publication type:
- Report
The Impact of Catecholamines on Defibrillation Threshold in Patients with Implanted Cardioverter Defibrillators.
- Published in:
- Pacing & Clinical Electrophysiology, 2005, v. 28, n. 11, p. 1147, doi. 10.1111/j.1540-8159.2005.09484.x
- By:
- Publication type:
- Article
Inappropriate Implantable Cardioverter Defibrillator Discharge Following Consumption of a Dietary Weight Loss Supplement.
- Published in:
- Pacing & Clinical Electrophysiology, 2004, v. 27, n. 9, p. 1317, doi. 10.1111/j.1540-8159.2004.00627.x
- By:
- Publication type:
- Article
A Case Report of Atrial Fibrillation Potentially Induced by Hydroxycut: A Multicomponent Dietary Weight Loss Supplement Devoid of Sympathomimetic Amines.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
- Published in:
- 2006
- By:
- Publication type:
- journal article
An Evaluation of the Impact of Oral Magnesium Lactate on the Corrected QT Interval of Patients Receiving Sotalol or Dofetilide to Prevent Atrial or Ventricular Tachyarrhythmia Recurrence.
- Published in:
- Annals of Noninvasive Electrocardiology, 2006, v. 11, n. 2, p. 163, doi. 10.1111/j.1542-474X.2006.00098.x
- By:
- Publication type:
- Article
The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The Impact of Catecholamines in Patients with or without Beta-Blockers on the Ventricular Fibrillation Cycle Length and Ventricular Fibrillation Cycle Length Variability.
- Published in:
- Annals of Noninvasive Electrocardiology, 2005, v. 10, n. 3, p. 305, doi. 10.1111/j.1542-474X.2005.00631.x
- By:
- Publication type:
- Article
Review: Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 9, p. 986, doi. 10.1177/0091270009355814
- By:
- Publication type:
- Article
A Preliminary Assessment of the Critical Differences Between Novel Oral Anticoagulants Currently in Development.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 9, p. 1004, doi. 10.1177/0091270005278084
- By:
- Publication type:
- Article
Critical Differences Among Beta-Adrenoreceptor Antagonists in Myocardial Failure: Debating the MERIT of COMET.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 1, p. 6, doi. 10.1177/0091270004269841
- By:
- Publication type:
- Article
Levosimendan: Implications for Clinicians.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 10, p. 1071, doi. 10.1177/0091270003257217
- By:
- Publication type:
- Article